Then we used The Cancer Genome Atlas (TCGA) gene expression and clinical data to further determine whether PRDM16 is associated with other clinical and pathological characteristics of lung adenocarcinoma patients. The gene discussed is PRDM16; the disease is lung adenocarcinoma.